Clinical Trials on Furmonertinib
Total 1 results
-
Peking Union Medical CollegeRecruitingNSCLC | Brain Metastases | Furmonertinib | EGFR-mutationChina
Sponsors and Collaborators
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Frankel, Amylynne, M.D.
- Edanz Group Japan Ltd
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- IRCCS Don Gnocchi, Milano, Italy
- Ruba Musharbash Nutrition Consultancy Center
- Michael J. Wesley, PhD
- Gulsah Ilhan
- King Baudouin Foundation
- Walgreens Co.
- Army Hospital, Percy
- Ana Paula Costella
- Pharmaspecific
- Fundación Pública Andaluza Progreso y Salud
- HeartPoint Global
- Korrus Inc.
- Center for Rare Neurological Diseases, Norcross, GA
- Laboratorios Viñas, S.A.
- Manmohan Cardiothoracic Vascular and Transplant Center
- View Full List
Medical Conditions
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Malignant Intracranial Germ Cell Tumor
- Cognitive Function, Social 1
- Impairment, Coordination
- Paralysis of Vocal Cords or Larynx
- Coagulation Disorder Neonatal
- Gastroenteritis Rotavirus
- Facial Involvement
- Kidney Damage
- Developmental Language Disorder and Language Impairment
- Cardiovascular Outcomes
- Ankylosed Teeth
- Pelvis Tumors
- Uncontrolled Type 2 Diabetes Mellitus
- Localized Unresectable Adult Primary Liver Cancer
- Menopause
- Severe Atopic Dermatitis
- Lung Neuroendocrine Tumor
- Brain Arteriovenous Malformation
- View Full List
Drug Interventions
- Interleukin-2
- LDEPA
- Transdermal estradiol
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- 5-Fluorouracil
- Insulin
- FHND5071
- Rituximab plus CHOP
- Apremilast
- Interferon beta-1b (Betaferon, BAY86-5046)
- Lidocaine/ ketamine
- Miglustat
- Dexmedetomidine
- Methotrexate
- Exendin 9-39
- Thiotepa
- Ozanimod
- Extended release guanfacine
- CD25 treatment
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Burundi
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Germany
- Contract Research Organizations in Ghana
- Contract Research Organizations in Japan
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Slovenia
- CRO list by country